Elite PharmaceuticalsELTP
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$0.36avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Elite Pharmaceuticals Inc. (ELTP) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Kelleher Financial Advisors ($365).
- Company
- Elite Pharmaceuticals Inc.
- CUSIP
- 28659T200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 500 shares bought, net +500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Kelleher Financial Advisors | 0.00% | Add +100.0% | 1,000 | $365 |
"% of holder's portfolio" is ELTP's weight in each manager's 13F, not the share of Elite Pharmaceuticals Inc. the manager owns.